Professional Documents
Culture Documents
PHILIPPINE
HEALTHCARE
INDUSTRY
Regulatory Review
December 2018
LIST OF ACRONYMS
BHDT Bureau of Health Devices and Technology
DAP Development Academy of the Philippines
DENR Department of Environment and Natural Resources
DOH Department of Health
FDA Food and Drug Administration
FGD Focus Group Discussion
HFSRB Health Facilities and Services Regulatory Bureau
HHRDB Health Human Resource Development Bureau
HMO Health Maintenance Organization
IRR Implementing Rules and Regulations
KII Key Informant Interview
LGU Local Government Unit
MDG Millennium Development Goals
MGRP Modernizing Government Regulations Program
NDHS National Demographic and Health Survey
NHIP National Health Insurance Program
NEDA National Economic and Development Authority
PHA Philippine Health Agenda
PHIC Philippine Health Insurance Corporation
PITAHC Philippine Institute of Traditional and Alternative Health Care
RIA Regulatory Impact Analysis
SDGs Sustainable Development Goals
SDN Service Delivery Network
TAHC Traditional and Alternative Health Care
TLSM Traffic Light Score Methodology
TAT Turn Around Time
TM Traditional Medicine
UHC Universal Health Coverage
WHO World Health Organization
TABLE OF CONTENTS
INTRODUCTION ........................................................................................................................................................ 1
Industry Background ............................................................................................................................................. 1
Industry Subsector Profile ................................................................................................................................. 3
Current performance of the industry ................................................................................................................ 4
Growth potential of the health industry............................................................................................................ 4
Regulatory environment of the Health Industry .................................................................................................... 5
Health Regulatory Thrust and Priorities of the Health Sector ............................................................................ 6
Regulations in the Health industry .................................................................................................................... 6
Regulatory Terminologies in the Context of the Health Industry ....................................................................... 7
Initial issues/concerns in Health Regulations .................................................................................................... 8
OBJECTIVES OF REGULATORY REVIEW ...................................................................................................................... 9
SCOPE OF THE STUDY ............................................................................................................................................... 9
Coverage: ............................................................................................................................................................. 9
Focus Areas for the Case Study ............................................................................................................................. 9
LIMITATIONS OF THE STUDY ................................................................................................................................... 10
RESEARCH QUESTIONS ........................................................................................................................................... 11
STUDY FRAMEWORK .............................................................................................................................................. 12
RESEARCH DESIGN AND METHODOLOGY................................................................................................................ 13
Sampling ............................................................................................................................................................. 13
Data Collection ................................................................................................................................................... 13
Data Management and Quality Assurance Processes .......................................................................................... 14
Data Processing and Analysis .............................................................................................................................. 14
RESULTS AND FINDINGS OF THE STUDY .................................................................................................................. 15
Results of Public Consultations ........................................................................................................................... 15
Results of the Health Industry Perception Survey Results ................................................................................... 20
PRIORITIES FOR RECOMMENDATION AND CONCLUSION ........................................................................................ 30
CASE STUDIES ..................................................................................................................................................... 31
CASE STUDY 1: RIA ON LICENSING OF BIRTHING HOMES................................................................................. 31
CASE STUDY 2: Licensing by Network .............................................................................................................. 38
VALUE STREAM MAP: STARTING A BIRTHING HOME .......................................................................................... 43
ANNEXES ................................................................................................................................................................ 46
Bibliography ....................................................................................................................................................... 46
Annex B. Data Collection Tools ............................................................................................................................... 47
BI. Draft Survey Tool ........................................................................................................................................... 47
BII. Draft KII/ FGD Tool ........................................................................................................................................ 55
Annex C. List of Respondents for Survey Method, KIIs and FGDs ......................................................................... 58
Philippine Renewable Energy Industry Regulatory Review
INTRODUCTION
Industry Background
Health regulation is one of the vital components of the Philippines health system. The health system is a broad
umbrella term, which includes the formalized health care systems, which are formalized; legally regulated financing;
and the provision of health (medical) services, inclusive of preventive, curative and palliative interventions provided
by trained health personnel. It covers health care of a specific population in a defined geographic location id being
demanded, delivered, financed, organized and utilized. (WHO 2000, The World Health Report Health Systems:
Improving Performance).
DOH is the lead agency and the technical authority of through means that respect, value, and empower
the Philippine Health Sector and the LGUs as the clients and patients as they interact with the health
administrative authority and stewards of the local system; and protect all families especially the poor,
health systems. Given this, the DOH with its marginalized, and vulnerable against the high costs of
regulatory clusters as the regulatory management, healthcare. It is guided by the values that all actions
serves as the focal, technical authority that develops that shall be done by the health system shall be
and enforces standards for health services, health implemented in accordance with the values of equity,
providers, and health devices, etc. Similarly, the local quality, efficiency, transparency, accountability,
government units, under the Local Government Code sustainability, and resilience. The PHA guarantees
of 1992, have regulatory functions as well in terms of that health system shall implement population- and
ensuring quality and accessibility of health services individual level interventions for all life stages that
given to the population. Both the DOH and LGUs promote health and wellness, prevent and treat the
perform regulatory function in the health industry for triple burden of disease, delay complications,
the public and private sector. facilitate rehabilitation, and provide palliation.
Improve access to health interventions through
The Philippine Health Agenda (PHA) (Figure I) functional Service Delivery Networks and
captures the current health industry framework, strengthening financial protection when accessing
which encompasses regulatory thrusts of the Nation’s these interventions through Universal Health
health system. The Philippine Health Agenda aims to Insurance. Research agendas shall be aligned to the
ensure the best health outcomes for all, without PHA goals and attainment of the SDGs; and results of
socio-economic, ethnic, gender, and geographic the researches shall be utilized as basis for policy
disparities; promote health and deliver healthcare directions and support.
The PHA framework for attaining universal health care is the FOURmula One Plus. The FOURmula One Plus for
health now integrates five pillars (Figure II): heath financing, health service delivery, health regulation, good
governance, and the cross-cutting pillar that is performance accountability.
UHC
Service
Financing Regulations Governance
Delivery
The main agency in charge of this work is the Regulation and Research, (3) Center for Cosmetics
Department of Health (Figure III). Under it is various Regulation and Research and (4) Center for Device
departments that have specific regulatory functions. Regulation, BHDT is now under FDA. The Philippine
The Health Facilities and Services Regulatory Bureau Institute of Traditional and Alternative Health Care
(HFSRB) set standards to regulate and license health (PITAHC) mandated to develop policies, standards
facilities and services such as hospitals, clinics, and guidelines for the practice of various traditional
birthing facilities, laboratories and other health medicine (TM) modalities and the manufacture,
establishments. The Bureau of Health Devices and marketing and quality control of TM products.
Technology (BHDT) is responsible in the development PhilHealth regulatory mandate is on accreditation of
of standards for radiation facilities and devices used health facilities and professionals and protect the
in medicine, dentistry, veterinary medicine, industry, National Health Insurance Program (NHIP). For Health
education, research, anti-crime, military, and personnel regulation the Philippine Regulation
consumer applications. The Food and Drugs Commission administers, implements and enforces
Administration (FDA) formerly Bureau of Food and the standards. PRC also administers examinations to
Drugs is in charge of four major areas: (1) Center for certify medical professionals and has the capacity to
Drug Regulation and Research, (2) Center for Food revoke license.
Current performance of the industry Ambisyon 2040 sets goals in health emphasizing the
quality of healthcare is equal to long life where
The National Demographic and Health Survey Report Filipinos can realize their full potential. This shall be
2017 (NDHS) showed gradual enhancement on done through promotion of healthy lifestyle choices,
specific health indicators. The NDHS report is done the development and utilization of new products and
every three years and is designed to provide processes that are safer cleaner and promote good
indicators on fertility, fertility preferences, family health. This is also in harmony with Goal 3 of the
planning practice, childhood mortality, maternal Sustainable Development Goals, which states that
mortality, maternal and child health, knowledge and countries should ensure healthy lives and wellbeing
attitude regarding HIV/AIDS, and violence against for all and for all ages.
women. The results are utilized in policy making and
program planning for the attainment of Sustainable Present reforms in the health sector are potential for
Development Goals (SDGs). Based on World Ranking enhancement of its regulatory mechanisms in health
in healthcare conducted by WHO, the Philippines in all levels of engagement in the health system.
ranked 60 behind Senegal and South Korea. This has These include the following:
been the country’s rank since 2000. Based on the 1. Continue to pursue Universal Coverage
Philippine Statistics Authority, health expenditure (improvement of PhilHealth core processes
increased by 10.3%. Although, the bulk of the and regulation of health financing).
expenditure is still from out of pocket payments of 2. Integration and harmonization of regulatory
households. Equitable health financing is a major mechanisms.
indicator in measuring improvements in health 3. Updating the medical act of 1959
systems and eventually health outcomes. The NDHS 4. Updating of the Cheaper Medicines Act
2017 report stated that 66% of population is covered (addressing issues in generic medicine)
by PhilHealth. This data differs on rural and urban 5. Strengthening the DOH licensing Authority
areas and also by type of membership. In terms of 6. Development of mechanism in taxing sin
health services the Philippines met the MDG criteria products and non-essential, unhealthy food
on infant and child mortality but failed to accomplish products.
the standard for maternal mortality, which at the 7. Development of restriction of harmful
moment is the focus of intervention and strategy in marketing and targeted sales
enhancing mother and child programs as well as 8. Creation of a sector-wide price regulation
family planning. 9. Mandating health impact assessment
10. Enhance the role of local government units
Giving value to patient rights, patient participation in health regulation (working in harmony
and respectful/compassionate care was the focus of with national agencies)
the Philippine Health Systems Review WHO 2011. The
Philippine Constitution of 1987 declares that The The crucial role of the health industry in improving
State shall protect and promote the right to health of the quality of life of Filipinos towards the
the people and instill health consciousness among achievement of, not only of economic, but also of
them. (Sec 15, Art II, 1987 Constitution); although social development is evident and essential. Given the
there are various policies that clearly defines patients’ gradual improvement in health reforms, addressing
rights to appropriate information and choice the gaps and issues in the health sector should be
study states that this had been more than a concept amplified and purposive.
than a practice specially for poor patients.
Reforms and enhancement in the regulation of the
Growth potential of the health industry health industry is an essential component of
addressing issues in the healthcare industry.
The National Economic and Development Authority Standards of healthcare and health service delivery,
(NEDA) identifies health as a major component in the and pricing are part of regulatory functions of not only
growth and development of the country. The the Department of Health but also the local
government units.
The framework below best sums the regulatory direction for health (Figure IV). Regulatory clusters of the DOH, along
with its sister agencies (e.g. PhilHealth, PITAHC, etc.) and the LGU, are the main governing bodies of health regulation.
Efficient regulation involves the development and The assurance of a business-friendly and yet equitable
maintenance of a clear regulatory structure with an health regulatory environment can in turn contribute
adequate understanding of regulatory jurisdiction. to responsive, efficient, and effective regulatory
The units of this structure are to enforce quality reform towards better health and economic
standards and equitable operations of medical outcomes. Below is the regulatory framework of the
services, facilities, human resource, devices & health sector which presents the relationship of
products, and financing. In order to do this, systems regulation on specific components and function of the
are processes for regulations are to be streamlined health sector. It explains that regulation is an integral
and harmonized amidst the different regulatory units part of the health systems structure, the products and
and agencies. Further regulatory improvements services it produce for the public and the processes
involve the monitoring and evaluation of regulations and systems it utilize to ensure that its mandate in
towards regulatory management, regulatory quality enhancing health outcomes for all Filipinos specially
improvement, and deregulation. the poor is met.
In accordance with the PHA, the main thrust for health regulations is to ensure the safety, quality, affordability, and
accessibility of health products, devices, facilities, and services, especially those commonly used by the poor. In
doing so, the DOH employs two main strategies: I) the harmonization and streamlining of regulatory systems and
processes, and II) the development of innovative regulatory mechanisms.
In the attempts harmonize and streamline processes In the attempts to develop innovative regulatory
and systems for regulations regulatory units of the mechanisms, the DOH is banking on the following
DOH is undergoing the following: action points:
The following illustrates the different agencies involved in health industry regulation as well as their respective
jurisdiction. Each agency has their respective issuances pertaining to regulatory standards, requirements, and
processes relative to their jurisdiction.
There are many types of regulatory outputs identified through regulatory terminologies that may vary in context per
industry. The following defines and provides nuances to these terminologies based on the current context of the
health industry:
1. Licenses- Licenses are mandatory requirements for business operations. Obtaining a license translates in
the full compliance to industry standards. These standards are usually set by the Department of Health. The
DOH provides, for example, licenses to operate, which means that a facility is compliance with all standards
needed in the conduct of business operations.
2. Accreditation- Accreditations are non-mandatory but it signifies the recognition of your business by a
regulatory agency. In essence, your service is recognized by said regulatory agency and thus, can avail the
benefits of recognition. For example, if a health facility is PhilHealth accredited it mean this facility is
recognized by PhilHealth and thus, can avail its health financing subsidy benefits. It is non-mandatory,
however, accreditation is pursued by most, if not all, health service providers and facilities given the effect
of the benefits on business operations and gains.
3. Permits- Permits are usually the jurisdiction of the local government unit. It typically allows a business to
operate within a local government area given that you comply with the local government’s requirements
(e.g. business permit, sanitation permit).
4. Certificates- Certificates are testimonies of the accomplishment of something. It certifies compliance to a
particular direction or rule of a regulatory body. For example, Food Safety certificates means that a business
has accomplished all food safety requirements, e.g. they are using food safe handling methods, storage
methods, etc.
In 2010 an article in health regulation by the Asian Other important concerns that need to be address
Institute of Management presented issues and include:
concerns in health regulation:
1. Lowering cost of health care to include
1. Despite the laws and standards in quality professional fees and medicines among
assurance and efficient investment, some others.
health facilities remain to be substandard 2. Regulating alternative, integrated and
and fragmented: This attributes to lack of complementary medicine: To date there is
enforcement and monitoring capacity of mushrooming of complementary medicine
agencies involved in the regulation process. providers and ensuring compliance to health
2. Lack of health human resource, technical standards remain to be a challenge for both
capacity and staff to enforce regulation: facilities and health human resource.
Human resource for health and regulation of 3. Other facilities that need continued,
licensed facilities and monitoring these appropriate standards development, and
facilities for compliance needs to be regulating are the hospice facilities,
addressed. rehabilitation centers, and geriatric facilities.
3. FDA’s failure to regulate unethical and 4. Equitable health financing and high out of
intensive marketing practices which led to pocket remain an issue to date. There is also
asymmetry of information where the the need to reduce out of pocket
consumer has less knowledge of the expenditures and the need to revisit and
products they are availing. potential regulate HMO’s role in financing
health.
5. Need to review and enhance Health Systems
and Regulatory processes like third party
accreditation, public partnership with
private sector and involvement of the civil
society in ensuring quality and equitable
health care delivery systems.
1. Health Facilities Turn Around Time for at different levels of care within a defined
birthing facilities geographic location (e.g. province wide, etc.).
The focus of this case study is to determine Licensing through this approach is the
the economic and temporal aspects of each current direction of the health sector given
step in the licensing turn-around time for that it is more systemic and theoretically
private and public birthing facilities. It will more efficient in terms of licensing
encompass both licensing processes for operations given that service delivery
initial start-up of said facilities as well as their systems are regulated and not merely
renewal. individual facilities and health workers. The
current approach is licensing and
2. Licensing by Service Delivery Network accreditation per facility, however there is
no regulation for systemic facility licensing.
Currently, there is no administrative order The case study aims to explore the potential
standardizing the licensing of facilities in the efficiency of this approach in relation to the
context of a health service delivery network. current approach used and its effect on
A health service delivery network is the public health outcomes as well as health
juxtaposition of health workers, facilities and business operations.
the capacity and capability of care providers
Further, as a result of temporal constraints, the scope 5. Food safety certification standards and
of the study is delimited in terms of case study and processes obtained from administrative
value mapping coverage. There are two case study orders from the FDA.
areas as mentioned in the previous section. In terms
of health facility licensing turn-around time (TAT), the shall be part of the discussion and partial analysis but
covered facilities will only involve birthing facilities shall not be part of the value mapping because of the
from the public and private sector. Licensing TAT for aforementioned limited time to develop the study.
both renewal and initial facilities will be included.
The aforementioned components of the health
The priority areas for the case study are the first two industry are the regulations that relatively affect
aforementioned topics (i.e. Turn-around-time for common, voluminous, and major business operations,
birthing facility licensing and licensing thru the service thus they have been the primary focus of the value-
delivery network. Inclusion of the third as well as the mapping component. Delimiting focus will allow for
depth of the third is subject to the temporal more comprehensive, quality value maps given the
delimitations of the research. temporal delimitations of the study; which in turn can
yield more strategic regulatory recommendations
With regard to the value-mapping component of the offering potentially higher economic and social
research, major regulatory areas to be mapped are as impact. Further, the aforementioned regulations
follows: have established standards and procedures that have
been implemented for a long time and may
• Health facility regulations of birthing facilities, potentially require revisiting and assessment to see
which are administrative orders that outline points for improvements. These operations given that
licensing processes and requirements (i.e. AO 12s they affect basic needs of the people (i.e. health care,
2012 obtained from HFSRB); as specifically pertains medicines, food, etc.) are also high-impact for both
for value mapping the birthing facility regulation the consumer and the service provider or business
requirement which has direct effect on maternal owner/ operator.
and child health, health outcomes.
RESEARCH QUESTIONS
The following are the formulated research questions for the study:
1. Which government agencies are included in regulating the setting up, regular operations and closing down
of businesses under this industry type?
2. How do these agencies regulate this industry/sector?
3. What specific regulatory policies/laws/legal issuances govern this industry?
4. What are the rationale, purposes and intents behind these regulatory policies/laws/legal issuances?
5. Do the industry players understand the rationale behind the specific regulation and the meaning of their
compliance?
6. What regulations related to the acquisition of materials and services from suppliers, the flow of information
required by the business, the delivery of goods and services to customer, and the flow of funds to and from
the business affect the industry?
7. What are the regulatory issues related to the setting up, operations and closure of businesses under this
industry?
8. What is the current level of compliance? How is compliance to these regulations monitored? What are the
repercussions for violators?
9. What are the “costs and benefits” of the regulations currently governing the specific industry?
10. Are there non-regulatory alternatives to the regulations that are suggested to be removed?
11. Are regulations regularly reviewed by concerned agencies? Are there improvements instituted to the ease
of doing business?
12. Should changes be introduced, what is the likelihood of compliance?
13. What benefits may be derived from the proposed changes?
STUDY FRAMEWORK
The figure below (Figure V) illustrates the framework of the study for the health industry.
As seen in the figure, the main methodologies to further unpack the regulatory atmosphere of the health industry
involve the conduct of key informant interview, focus group discussions, a survey, and a comprehensive desk review.
Various forms of health regulations from different levels of the regulatory hierarchy will be reviewed, mapped, and
profiled. The study also aims to unpack the perceptions, awareness level and experiences of both the regulator side
and the regulated with regard to these regulations for a holistic picture of their strengths and weaknesses better
regulatory recommendations and directions.
Analysis of the obtained data shall mainly involve the conduct of RIA and TLSM so as to determine empirically the
costs and benefits as well as the effects (intended or unintended) of these regulations with respect to the time and
economic investment of the consumers, the public and the regulating agencies.
The outcome of which is to unpack the current level of regulatory efficiency and equitability of the health industry
as well as recommended directions for its improvement. In the context of this study, regulatory efficiency has
economic and temporal components for both regulatory enforcement/ implementation and compliance processes,
respectively. In essence it aims to unpack the level of regulatory burden (in terms of time, resource and monetary
costs), as well as movements to reduce this.
Given that the health industry attempts to balance both equitable service aside from health business sustainability
and economic profit, another outcome is to describe and improve the equitability of health regulations, meaning
that the services although are economically sustainable from the business owner and provider perspective, are still
accessible, affordable, and quality assured for the consumers who will avail said services and products.
In essence, there is a balance between equity and efficiency as facilitated by regulations and non-regulatory
alternatives.
Sampling
The participants included in the study are sampled purposively. Key informants and FGD participants are selected
based on their expertise and experiences in either regulating or complying to health regulations. A list of possible
participants for key informant interviews and FGDs are outlined in Annex D.
Survey participants are sampled purposively also, The selection of regulations and case study focus
complying with the minimum number of participants areas are also purposive and are determined based
prescribed by DAP (i.e. n>50). A list of different types on the concerns and issues voiced out through public
of businesses within the health industry was outlined consultations with stakeholders both in the regulator
based on desk review (e.g. types of facilities or (e.g. DOH, PHIC, PITAHC, etc.) and regulatee (hospital
businesses regulated by DOH). A representative from personnel, health providers, etc.) side. The focus
Luzon, Visayas, and Mindanao from each type of areas are the ones with the most potential impact to
business establishment, who is familiar with health industry regulations. Issuances selected are
regulations and regulation compliance for business administrative orders on health facility licensing,
start-up, operations maintenance, and closure, specific to birthing hospitals (e.g. AO 2012-0012, etc.),
respectively will serve as the survey respondents. A and administrative orders governing foreign
list of possible survey participants can be seen in donations. Given that there are many administrative
Annex D. Based on the list a total sample of n=68 orders pertaining to licensing, standards, and quality
participants will be involved in the study. regulations for both the case study and value-
mapping component, a better outline of these
A list of participants with contact details can also be issuances will be provided after the desk review.
seen in Annex D.
Research associates shall ensure the completeness of Excel will be utilized to facilitate the conduct of RIA,
survey forms as well as the documentation of especially for the cost-benefit analysis. Frequencies
qualitative data obtained through the various data and other quantitative descriptors will also be
collection methods such as KIIs. Data quality checks generated through excel.
by the lead consultant/ researcher will be conducted
semi-monthly to further ensure data quality. Qualitative data obtained through KIIs and FGDs will
be documented and summarized using MS word.
Given that quality data procedures also encompass Thematic analysis will be used to cluster responses
ethical considerations, informed consent will be into themes, which can provide insight on regulatory
obtained prior to data collection. Adequate burdens, in/efficiencies, strengths, and gaps as well as
safeguards to maintain participant confidentiality and possible recommendatory directions to address these.
comfort will be conducted. When relevant, codes or
aliases will be used to protect participant privacy. All Regulations will also be subjected through value
collected data will be stored appropriately. In essence, stream mapping, which outlines the requirements
hard copies will be kept in organized folders stored in and processes for all the steps in business operations
cabinets with lock and key, and soft copies will be (i.e. from start-up, to maintenance, to closure). Value
password protected. Data collected will be used stream mapping can flesh out processes, which add
solely for the DAP study towards the improvement of unnecessary burden to the business owner,
the health regulatory atmosphere. duplicative procedures, etc. It can also identify the
time and costs allotted per requirement and
Validation through Key Informants Interview and procedure. Data analysis tools follow the DAP tools
FGDs will also be conducted to ensure that an and templates for conducting value stream mapping,
accurate and relatively complete picture of the health RIA and TLSM.
industry regulatory experience was captured by the
study.
Three public consultations were done mainly in Luzon, implication to the services they render. These
Visayas and Mindanao out of these consultations stakeholders came from different sides of the health
common issues were raised by the respondents with sector starting with the pharma industry, public and
regards to health regulation. Major themes that private hospitals owners and administrator,
surfaced during the public consultations are in line representatives from the medical societies, birthing
with restrictions brought about by over regulation in homeowners and staff and also consumers of health
the health sector. Participants of the said products and services.
consultations are both from the health regulatory
bodies in the national levelheaded by the Department The presence of various stakeholders during the
of Health and PhilHealth. National and regional consultations and focus group discussions enable the
agencies engage in health regulation such as the team to get inputs on a holistic level and in
Department of Environment Natural Resources, consideration also of geographic location these
Department of interior and Local Government were consultations were done in the three main Island
also present during the consultations. Apart from the groups (Luzon, Visayas and Mindanao). Results of the
major health regulators stakeholders in the health activities are utilized as part of the study results
sector were also present to share their thoughts and together with the perception survey and key
experience regarding health regulation and its informant interviews.
1Issues were taken from initial desk review, industry dialogues, and initial key informant interviews with
health industry regulators and regulatees
2Hindrances in business operations have economic repercussions to business sustainability. It pertains to the
economic side of the health industry. Standard quality and relevant impact pertains to true social gains as the
health industry is not only a viable economic operation but it has social mandates and responsibilities for the
populace
HINDRANCES IN • Distribution of facility and business acumen of operators are not taken into
ENSURING STANDARD consideration in regulations, which affect health service access and business
QUALITY AND sustainability. Not all health providers are business people and vice versa.
RELEVANT IMPACT • Collaboration with private sector in terms of aiding government owned health
businesses or facilities is inadequate thus health access and health resources are
not fully maximized.
• Ensure appropriate fees for the standard quality of medicines, drugs and products,
especially for the FDA.
• Inadequate police power of regulations that compromise quality of care. “Policies
with no teeth”, which can lead to deviant businesses and corruption venues.
Apart from public consultations done in the three providers (APE) of birthing facilities (look
major Island groups focus group discussions were also into regulation as income)
done and common themes regarding regulations in • Nursing staffing based on number of beds
health and issues were also raised as well as and not on based on average occupancy rate
recommendations. There were common themes that • Open up point of care to private healthcare
surfaced from the activities from the feedback of providers
stakeholders. They stated that regulatory agencies • Bidding process should include distribution
should explain to end user the rationale behind the • Tapped the private sector to contract out
regulation in order to provide end users guidance and including facility
entice compliance. There is also a need to standardize • Law should be precedent from any policy
requirements on licensing and accreditation regulation
(different standards per region). Policy on regulation • Strengthen the role of Food and Drugs
in relation to licensing should consider level of Administration (FDA) to support regulatory
business i.e requirements for private birthing facility and enforcement function
should not be like a requirement for a private • FDA to look into the calculations of variable
hospital). fees
• Impact assessment that has been done by
If the end users are informed and engage in the the FDA/ compare filing fees in other
rationale and use of regulation it will enhance countries
predictability that shall result in compliance with the • Most PhilHealth circulars contains no
said health regulation. There was also a suggestion to transition of instructions
make the license to operate of the DOH for three
• Regulation should look into small enterprise/
years. Other relevant comments from the group are
how to strengthen the multiply policy for
the following:
these enterprises are different from big
facilities and make sure that these facilities
• Review standards that increase cost: i.e.
exists in the industry.
requirement on the building of excessive
• Implement the Universal Coverage to lower
number of ramps for PWDs.
the cost of medicines
• Repetition of requirements Quezon City
• Regulators should improve transparency in
requires Annual Physical Exam for service
all aspects
On the Case study 1: Birthing home issues for • I license facilities by network
consideration: • Services defined and support services
including programs
• Laws take precedence need to Rationalise • Blood network/HIV network testing/ ABCT /
laws - Remove redundancy (proceed to Mental Health/ MBHFI
Environmental Management Bureau (EMB)
• Implementing IRRs should converge toward What should be included in the Licensing by network
a mother health policy- MNCHN (LBN)?
• A comment - Operating a birthing home is a
social enterprise. No economies of scale • Network blood/pharma/ birthing facilities/
among 2 bed facilities therefore inefficient hospitals
• Look into Midwifery law, RA7392, sec. 23 • Health financing (ensuring financial access)
(Philhealth)- (MOA) and financing the system ( prioritizing
• RA 9288 NewBorn Screening law (Philhealth) benefits, paying for services)
- birth certificate requirement • Human Resource System
• Holidays
• Separate system for Birthing homes What legal instruments are needed to implement the
• OT for small Philhealth claims (birthing LBN?
homes), others operate only during office
weekdays • Creation of DOH administrative order
• LGU and concerned agencies: (integrate to UHC law)
o EMB • Creation of ordinance/Resolution
o PD 1586: Phil Environment Impact integration of licensing by network
Statement System • Utilization
o RA 9275: Phil Clean Water Act of • Creation of MOA DOH RO 7 with health
2004 facilities
o RA 6969: Toxic Substances, • Payment method dependent on the
Hazardous and nuclear wastes timeliness of payment and payment terms
control act with partners
o DAO 2014-02 Revised Guidelines • Mental health medicine procurement
for Accreditation of PCOs (bidding/ VSMC)/ Community based mental
o PD 856, Sanitation Code DoH (Is health program supported by other regions
there a need for this)? lodged initially in hospitals
• Trained doctors in district hospitals in mental
On Case study 2: Common themes regarding health
licensing by network • 40 indigent patients for 3 months (once a
month shot)
• MGRP and Universal Healthcare based on • Continuity hospital in mental health LGU has
FourMula 1 Plus specific designated hospital beds partnered
o MGRP support UHC in terms of with GLOBE i.e. Pinamunahan
ensuring efficient health regulation • Start in Bugo under Bugo ILHZ Basameda /
• Regulatory (licensing by network) Bantayan Island /Camotes Island
• Health Industry Profile • Joan Santiago to develop a concept note
o Issues Confronting the health (legal instruments , process)
sector • Inclusion in the PhilHealth package
o Vision, mission, goals, core values
• Study Framework Licensing by SDN Other Comments and suggestions:
• Health Industry Regulatory Framework
• Value stream map • Deployment of HR staff ( deploy 1 nurse per
5,000 pop) proposal HFIDP
What is your perception on the licensing by network? • Among the provinces Cebu already
established SDN lacks governing body /
• Role naming is not just carrying them in • Standardize service package in defined
terms of licensing but also to identify what facility
the critical equipment’s should be • VMSC accredit Family Med doctors MHO
• Human Resource as problems: companies doctors i.e Siargao to capacitae Siargao
are ready to provide outsourcing contracting hospital no doctors put doctors initially
i.e. radiology radio tech services second to improve the trust and confidence
• It may be ok initially, but the ultimate goal is to use the hospitals (family med, surgeon)
to be the APEX (first capacitate these evreyt ime na nadun lang tao ng VSMC
hospitals but eventually they will be the one • Mag apply Sotto pero I deploy sa Siargao
to take care of developing the hospital) VMSC accredit as fellow
• LBN will strengthen gate keeping i.e. cardio • Application of accreditation of fellowship is
clinic basic services/ pathologic in lower level in VSMC
hospital
Note: A total of 72 respondents answered the perception survey on the impact of regulations on businesses for the
Health industry. However, not all respondents provided responses for all questions. For each “major item”, the
sample size of respondents is indicated.
Description of Respondents
Types of Businesses. A total of 71 respondents provided information on the type of business they own. Majority of
the business types are corporations (41 respondents; 57.7%), while 20 are sole proprietorships (28.2%).
Business Locations. Majority of business owners are located in Luzon (63.9%. 46 respondents out of 72). 19.4% (14
respondents) are located in Mindanao; and 9.7% (7 respondents) are located in Visayas. 6.9% (5 respondents) have
multiple locations all over the country.
Type of Business by Capitalization. Of the 70 respondents that provided their business capitalization, 18 businesses
qualify as microbusinesses with a capitalization of up to Php 3, 000, 000; 12 are small businesses with a capitalization
of Php 3,000,001 to Php 15, 000,000; 18 are medium businesses with a capitalization of Php 15, 000, 0001 to 100,
000, 000; and 22 are large businesses with a capitalization of Php 100, 000, 001 and above.
22
18 18
12
Of the 71 respondents who provided an answer, majority of the businesses have been operating for more than 10
years (49 respondents), 29.6% have been operational for two to 10 years (21 respondents), and 1.4% (one
respondent) reported being operational for less than two years.
Listed below are the regulatory agencies, which businesses deal with the most. The agencies are arranged in terms
of importance to the business owners (n=69).
Top 10 agencies are cross-cutting amidst all businesses. Those listed below were mentioned by only approximately
15% of the respondents. The agencies from 18 and onwards were only mentioned by one business and are listed as
the “least impactful” agency dealt with.
Reasons for Interaction. Top 5 reasons for interaction with said agencies are as follows I) Registration and renewal
of permits (n=68 out of 72 respondents), II) Inspection of products/ premises (n=56), III) accreditation of products/
services/ personnel, etc. (n=54), IV) provision of required regulatory information (n-54), and V) remittance of
government shares (n=40).
Registration Inspection of
and renewal products/ Accreditation
of permits premises
Provision of
regulatory Remittance
information
Interaction Frequency
Table 5: Number of Businesses who Reported their Interaction Frequency per Year by Type of Interaction
Interaction frequency per Year Inspection/ Audit Information Submission
Once a year 8 respondents 33 respondents
Twice/ Two to three times a year 9 7
More than twice/ 4-6 times a year 50 11
More than 6 times a year -- 21
Not applicable 3 --
Figure 11: Perception of the Respondents on the Interaction with the Regulatory Agents
As seen in the figure above, major issues with regard to regulations is with regard to consultation and mutual
regulation understanding, which is affected by the volatility and unpredictability of policies. Lack of consultation can
lead to regulations that are dissonant with industry context, which delimits rationale understanding an in turn affects
compliance efficiency. Lack of mutual understanding can also be due to untimely announcements of changes,
rendering the regulations unpredictable, which again influences compliance efficiency and ease. Interaction with the
regulatory agencies seems to be imbued with communication and information exchange issues. Perceptions on
Regulatory information will be discussed in the succeeding section.
With regard to regulation awareness, 69 respondents provided answers. 20 of the respondents are very familiar with
industry regulations, 28 reported being familiar with the regulations, and 21 reported being only moderately familiar
with said regulations.
REPORTED REGULATION
FAMILIARITY OF RESPONDENTS
Moderate Familiar Very Familiar
29% 30%
41%
More respondents have positive perceptions on the nature of the regulation information in terms of their availability,
timeliness, etc. although the increase is marginal relative to the number of respondents who disagree or have
relatively negative perceptions and those who have neutral perceptions.
All regulations, when considered applicable to the context of the business, have major impact since failure to comply
may lead to the end of the business.
More respondents perceive tax, health, employment, and administrative regulations as easy to comply with, while
customs, infrastructure, technological, and environmental regulations as difficult to comply with. Difficult
regulations pertain to infrastructure or facility requirements, human resource requirements, fire safety
requirements, and environmental requirements about safe disposal.
Major issues due to difficulty of regulation compliance is due to policy volatility or unpredictability (i.e. there are fast
changes, which the owners have difficulty tracking and the regulator end has insufficient capacity to implement
these changes as well). There is also limited human resource to monitor and implement regulations, which creates
backlogs and makes compliance difficult. Thus, turn-around-time serves as a major issue, which hinders compliance.
Further, there are additional requirements, which business owners deem unnecessary, laborious or hinder business
efficiency. There is also inter-agency overlap of requirements, which makes compliance redundant, confusing or
laborious. These are made even more difficult due to the inaccessibility of agencies (e.g. because there is limited
human resource to tend to the needs of the business owners as well the location of some agencies).
All these issues lead to the predominant perception (33 out of 63 respondents) that regulations are inadequately
enforced.
Information Submission Compliance. One of the major trends in addressing administrative burden is through
automation (i.e. the online transactions for regulatory information). Based on the survey, majority of the participants
utilize online forms, granted that they are available (Lack of online forms is the main reason why not all respondents
utilize this).
27%
Yes
No
73%
Majority of the respondents (77%; 54 out of 70) claimed that online forms (assuming that online portals are fully
functional and that hybrid models (i.e. those that have online portals but still require hardcopies) are highly effective
since they reduce costs and make transactions smoother and easier. Provision of data also becomes easier across
agencies.
Effectiveness is reduced however if the agency does not have the sufficient capacity to implement, maintain and
sustain the online forms or if they have hybrid models which makes the administrative burdens redundant.
Perceived Effectiveness of
Online Forms
23%
Effetive
Ineffective
77%
No sustainable Software or
automation technological
capacity glitches
Unsure if
documents are
Hybrid models
received and
checked
Cost of Compliance
There is a lot of variation in the reported estimate for the time spent annually (total workdays per year) in complying
with regulations. The reported mode (n=12 out of 56) is 30 days. The range of estimated working days for regulatory
compliance is from 3 days to 365 days. Average is 88. 64 days.
Majority of the participants (n=38) agree that regulatory breakdowns are clear and relatively transparent. They (n=31)
also perceive the costs as reasonable. 21 out of 67 respondents claim that there are other fees collected for
regulation compliance other than what is published, while the rest claimed they have not encountered such fees.
There was no mention on what these fees are and the rationale behind them.
Perception on Overall
Regulatory Environment
12%
27% Weakly regulated
Fairly regulated
Over reglated
61%
61% of the respondents (39 out of 64) claimed that the overall regulatory environment is fairly regulated; 27% (17)
claimed it is over regulated, while 12% (n=8) claim that it is weakly regulated.
Majority claim that regulations are necessary, relevant, and beneficial to business (i.e. its benefits outweigh its cons)
since it provides standards and quality assurance measures, however regulatory consistency amidst regulatory
agencies can be improved.
Other issues and rooms for improvement are as follows: most regulations are not conducive to business expansion
and growth, especially due to overregulation, duplication of labor, unpredictable policies, long turn-around-time,
and inter-agency overlap. It is recommended by the respondents that although regulations are highly important
given that they assure and certify the quality of a business, which aids the business become trust worthy for
consumers, it has to reduce the burden of compliance and enhance its efficiency.
Nevertheless, majority of the respondents claim that regulations are highly beneficial to the health industry.
PERCEIVED EFFECT OF
REGULATION TO INDUSTRY
Beneficial Not Beneficial
25%
75%
Current developments in the health sector specifically education campaigns for service providers. Another is
on the Implementation of the Universal Healthcare to develop a prestige mechanism to ensure
law should be considered in rationalizing and compliance and essential in assuring improvement in
developing additional policies in regulation as well as the system is to strengthen automation capacity and
revisions of existing regulation that are repetitive and support for service provider through system
costly. There is also a need for comprehensive and enhancement and development of appropriate IT
further study on health sector regulations and its infrastructure and communication strategy. A mixed
implication to the goal of the Department of Health approach in regulation and non-regulation is also
as the lead steward of Health of the country in recommended. Starting with the combination of
achieving its primary goal of enhancing health policy development (in phases) and non-regulatory
outcomes and improvement in the quality of life of all initiatives as presented above.
Filipinos.
The recommended regulations are aligned based on
Looking at the results of the consultations and the findings of all collection and analysis methods
perception survey priorities for recommendation from VSM to RIA, from consultations to the survey.
were formulated. On the regulatory aspect, one is Undergoing the proposed recommendations have
that there is a need to develop policy on first revision policy coherence: both bank on UHC Law towards
of administrative order (AO) & Circular on birthing social and economic efficiency. Both are also aligned
homes towards deregulation (i.e. PHIC becomes M&E, with the recently passed UHC Law as well as other
LGU for continuous M&E) and second is that there is international commitments
a need to Develop an administrative order (AO) &
UHC IRR for Systems/Network accreditation.
CASE STUDIES
The AO stipulates licensing requirements for both private and public birthing homes.
DOH, specifically the Health Facilities and Service Regulatory Bureau (HFSRB) is tasked to monitor the compliance to
this issuance. Lack of compliance can lead to non-licensing of the facility, which prevents business operations. Non-
compliance during continuous monitoring processes can also lead to closure of facility or inability to continue
operations
PROBLEM:
Inadequately distributed number of continuously compliant birthing facilities, which leads to gaps in the provision
of quality maternal health care
are also regional discrepancies with FBDs, which in providers offering contextually appropriate
turn can have its effect on maternal mortality. care.
Currently, only 78% of live births are facility-based, • Regulatory Institution.
wherein 84% is attended by a SBA although these • DOH streamlines processes, assures quality
figures have been relatively, statistically plateauing care, lowers maternal mortality, service in
for the last three years. This figure, although high the un-served
nationally, have great fluctuations regionally and • PHIC. Accredited facilities, more payment for
geographically amidst other demographic services, reduces out of pocket,
characteristics, wherein urban areas have higher • LGU. As program implementers, they are
percentages compared to rural ones; and NCR has the able to have good health outcomes for the
highest percentage compared to ARMM, which has populace which it serves. Also allows for
the lowest. Further, higher income mothers have a sustained business for LGU-ran facilities
higher percentage of undergoing FBDs attended by • Service Provider. Added income, ability to
SBAs compared to lower income mothers (NDHS, conduct business and become economically
2017). productive
Factors that contribute to these discrepancies is a Description of Impact
matter of health literacy influenced by socio-
demographic characteristics, as well as barriers to • Reduction of maternal mortality costs and
access and affordability. There is an inadequately burdens on the family and community
distributed number of birthing facilities who meet • Increase economic productivity of birthing
and continuously comply with quality standard. facilities
Licensing of facilities is part of DOH’s mandate, while • Reduction of out of pocket expenditures due
its accreditation is dependent on PHIC- both to increased number of accredited facilities
regulatory agents for quality facility capacity. There is • Quality care guaranteed
a need to harmonize and streamline birthing facility
licensing to ensure there are adequate facilities with Level III: Quantification of Effects
its respective competent providers, and that these • Effects of inadequate policy will
facilities maintain quality service provision and contribute to stagnation in maternal
business operations. health outcomes, which have social and
To surmise, despite the importance of facility-based economic costs on the individual, family,
delivery, not all mothers are able to avail of quality and community level.
facility-based delivery given the inadequacy of • Ensuring quality care through
facilities compliant to licensing standards. Inability for appropriate birthing facility licensing
facilities to get licensed not only have economic costs can limit hospitalization costs,
in terms of hampering business operations, but also opportunity costs, etc. due to maternal
social costs given its impact on maternal and infant and child morbidities and mortalities
health. due to a lack of access to quality birthing
facilities.
Licensing issues for facilities include, but are not
delimited to: I) Difficult licensing processes and Level IV: Partial Monetizing
procedures, and II) varying interpretations and
• Direct Licensing Costs: transport, food,
enforcement of licensing standards at different levels
greater hospitalization costs due to
of the regulatory institutions.
more severe morbidities, mortality
Result of Proportionate Analysis costs, etc.
• Indirect Licensing Costs: Opportunity
Description of Groups Affected & their Respective cost for the consumer and the service
Impacts provider. The latter is due to delayed,
halted or discontinued business
• Consumers, the family, and the community.
operations.
Improved access to quality maternal and
• Days allotted for Licensing Compliance
neonatal care, wherein quality involves the
due to cumbersome licensing
respectful encounters with proficient service
Objective: To increase the number of continuously compliant birthing home facilities providing quality maternal care
for mothers within three years
Specifically:
• To streamline licensing processes for public and private birthing facilities within three years via deregulation
• To improve synchronization of licensing regulations by regulatory institutions within three years
• Deregulate and render PHIC and LGU as main enforcers so as to ensure true quality of service, remove
duplication of labor and regulations, as well as standardize process
o Cost-effective
o Logical or coherent
o Holistic
Identification of Alternatives
Option 1: Do Nothing
• Lack of quality facilities and service providers that can cater to mothers’ and infants’ needs
• Hindrance to business operations of lying-in facilities
• Continuation of varying standards and cumbersome licensing processes
Option 4: Mixed
Evaluation of Alternatives
Naturally occurring cost for start-up and MMR Costs of illness: Government spending on
licensing compliance to varying • 0.46 million dollars for illness
requirements maternal deaths
Loss of investment come
• 1,500,000 start-up cost • 7.36 million maternal
closing of facility due to lack of
• Compliance to unnecessary morbidity
business acumen
requirement can go up to 1,280,000 • Cost of burial
• Economic 234.6 dollars/ person/facility
halting/Productivity Loss due to inadequate facility care
=Loss of 51 million per year
• Continuous and increased cost savings due to illness prevention and burial
Benefit 1 costs
• Continued economic productivity
AV 1,952,616,749 12,406,962,318
Assumptions/ Caveats for CBA: information available. Costs and benefits are dynamic
thru the 10-year period. Refer to excel sheet on CBA
No attributable probability of policy effect to delimit for better breakdowns of costs and benefits.
corresponding change in maternal mortality and its
reduced costs. (i.e. there are parallel interventions Interpretation:
that may contribute to the benefit, the policy being
one of them, however the latter cannot be isolated. Although both initiatives have positive NPVs, which
mean both are economically viable options, mixed
Quantification of cost of illness was lifted from approach implementation has higher yield and is
literature covering low income countries such as more cost-effective than the existing regulatory
Africa, conditions may differ in the Philippines. Use of environment.
these estimates are due to delimitations in the
Stakeholders Analysis:
The result of the stakeholders analysis indicates that that the major implementers in the management and regulation
of birthing facilities as a service provider such as the Department of Health, PhilHealth, LGHUs, PRC and the midwives
societies should be manage closely in terms of policy making and operationalization of these policies. DENR on its
part as a national agency involved in the regulation of environmental safety should be complied by stakeholders. As
for the NGS’s/CSOs and mothers and their families information with regards to the services and privileges as well as
the responsibilities of the consumers should always be in p[lace and updated.
Consultative Mechanism:
As for the consultative mechanism the team conducted key informant interviews with policy makers in DOH and
PhilHealth and results of the consultations were presented to stakeholders and policy makers. Below is the table of
the consultation and stakeholders of the activity.
PROBLEM
Problem Analysis/ Rationale for improvement: (5.11); and (d) monitoring and evaluation of the SDN
(5.20).
Provision of the UHC Law defines the network of
health facilities that shall render health services to Also, quality health service provision from health
specified clients and in different levels of care facilities are part of international commitments on
depending on the case of the patient/client. Health meeting the sustainable development goals. It is in
facilities shall be the main provider of care per this context that improving policy on licensing of
catchment area. The Administrative Order on Service health facilities can contribute to business continuity,
Delivery Network “AO 2014-0046 Designing the SDN competitiveness, and economic productivity of the
for Universal Health Care” (UHC ) provides guidelines health care service providers and consumers through
for the establishment of SDN to efficiently and illness reduction for the latter.
effectively cover the needs of priority groups and the
general population for UHC programs and projects. As Proportionate Analysis
support another AO was developed “AO 2017 – 0014 Description of Groups Affected & their Respective
Framework for Redefining Service Delivery Network” Impacts
which provides new guidelines on the establishment
of SDN. The function and services of public and • Consumers, the family, and the community.
private health facilities is a major component of the Improved access to quality health care,
referral system function of the service delivery wherein quality involves the respectful
network. encounters with proficient service providers
offering contextually appropriate care.
The development of SDN is a response to the • Regulatory Institution.
fragmented health service delivery system and facility.
• DOH streamlines processes, assures quality
Service delivery network, as defined by the
care, lowers health morbidities and
Responsible Parenthood and Reproductive Health
mortality, service in the un-served
(RPRH) Law, refers to the network of health facilities
• PHIC. Accredited facilities, more payment for
and providers within the province- or city-wide health
services, reduces out of pocket,
system, offering core packages of health care services
• LGU. As program implementers, they are
in an integrated and coordinated manner.
able to have good health outcomes for the
Furthermore, it specified that service delivery
populace which it serves. Also allows for
network should be established and organized by LGUs
sustained business for LGU-ran facilities
in coordination with DOH to effectively deliver
• Service Provider. Added income, ability to
reproductive health care services to priority
conduct business and become economically
population.
productive
Rule 5 of the Implementing Rules and Regulations
Description of Impact
(IRR) states that the Department of Health shall
develop specific guidelines for these sections: (a) • Reduction of illness costs and burdens on the
identifying needs of the priority population within the family and community
SDN (5.10); (b) mapping the available facilities in the • Increase economic productivity of all health
SDN (5.09); (c) designating of population to facilities facilities from all levels
• Reduction of out of pocket expenditures due more severe morbidities, mortality costs,
to increased number of accredited facilities etc.
• Addresses HR and other logistical resource • Indirect Licensing Costs: Opportunity
concerns due to better resource pooling at a cost for the consumer and the service
systems level provider. The latter is due to delayed,
• Quality care guaranteed halted or discontinued business
operations.
Level III: Quantification of Effects • Days allotted for Licensing Compliance
• Effects of inadequate policy will due to cumbersome licensing
contribute to stagnation in health requirements can also increase indirect
outcomes, which have social and costs.
economic costs on the individual, family, Level V: Full Monetizing
and community level.
• Ensuring quality care through • Impact costs to families with health
appropriate public health network afflictions and other morbidities that
licensing can limit hospitalization costs, can be debilitating in nature. Household
opportunity costs, etc. due to operations are hindered, which impacts
morbidities and mortalities due to a lack not only the patient but also the
of access to quality facilities and patient’s caregivers.
providers • Impact costs to Community: Hindered
economic development due to halted
Level IV: Partial Monetizing businesses as well as incapacity of
consumer to economically and socially
• Direct Licensing Costs: transport, food,
participate due to illness.
greater hospitalization costs due to
Objective: To develop systems for an integrated health care delivery network accreditation
The figure below presents the Universal; Health Care Integration (UHC) between levels of care from the basic or
primary up to the unified health network based on provinces and cities.
Identification of Alternatives
Option 1: Do Nothing
• Lack of quality facilities and service providers that can cater to needs and inequitable access
• Hindrance to business operations of health facilities and providers
• Continuation of varying standards and cumbersome accreditation processes and understanding of the
policy
• Crowding at various levels of care due to inadequate resources and gatekeeping failure
• Develop UHC Law IRR: Local Health Systems Integration and systems accreditation
• Policy development for the systems integration and systems accreditation for a more efficient and effective
health care delivery systems: non fragmented, access, quality and safety and institutionalizes enforcement
initiatives
Evaluation of Alternatives
Consultation Strategy
• Conduct of key informant interviews with policy makers in DOH, PhilHealth, LGU: Province & City and direct
health providers and facility managers
• Presentation of consultation results to stakeholders and policy makers
Part of the case study output is the value stream mapping of the process of starting a birthing facility up to the actual
licensing approval and eventual start of operation of the birthing facility. The first figure shows the step by step
procedure of the process and the agencies and institutions that the business owner should engage with to comply
with the licensing requirements. Included in the figure are marks where there are duplication on the process for
example SEC registration and DTI registration both requires article of incorporation. The second figure is the
computation of reduction of requirements on the process if duplication is removed and process is rationalized.
Figure three and four presents the length of time and distance needed to acquire license per agency starting with
getting a barangay clearance until finally release of license from the DOH and accreditation from PhilHealth which
will take almost 55 days or two months. Figure four shows the length of time and distance for renewal of license
and accreditation from PhilHealth.
Figure 26: Value Stream Map for Renewal of Accreditation of Birthing Homes and Possible Closing due to Non-
compliance
ANNEXES
Bibliography
Department of Health, A.O. 2017-006. Redefining Service Delivery Networks, Manila, 2017
Department of Health, A.O. 2017-0012. Guidelines on the Adoption of Baseline Primary Health Care Guarantees
for All Filipinos, Manila, 2017
Department of Health, A.O. 2016-0038. Philippine Health Agenda 2016-2022, Manila, 2016
Department of Health, A.O. 2014-0046. Defining of SDNs for UHC. Manila, 2014
Department of Health(A.O.) No. 2012-0012 Amendment to Administrative Order entitled “Rules and Regulation
Governing the New Classification of Hospitals and Other Health Facilities in the Philippines”
Huntington, D., Banzon, E., and Recidoro, Z. Systems Approach to Improving Maternal Health in the Philippines.
Bulletin of the World Health Organization, 90:104-110.
Lavado, R.F., & Lagrada, L.P. (2008). Are Maternal and Child Care Programs Reaching the
Poorest Regions in the Philippines? Philippine Institute for Development Studies Discussion Series 30. Retrieved on
December, 2016 from http://dirp3.pids.gov.ph/ris/dps/pidsdps0830.pdf
NEDA (2015). Philippines 5th Progress Report on the Millennium Development Goals. Retrieved on December,
2016 from http://www.neda.gov.ph/wp-content/uploads/2014/08/MDG-Progress-Report-5-Final.pdf
Ross, C.E., Masters, R.K., & Hummer, R.A. (2012, November). Education and the Gender Gaps in Health and
Mortality. Demography, 49(4), 1157-83
United Nations. Sustainable Development Goals Indicators. Retrieved on April 11, 2018 from
https://unstats.un.org/sdgs/indicators/indicators-list/
Good day! Your business is invited to participate in a survey, entitled “Perception Survey on the
Impact of Regulations on Businesses in the Philippines.” This is being conducted by the
Modernizing Government Regulations Program Office of the Development Academy of the
Philippines (DAP) for five (5) industries: tourism, healthcare, construction, renewable energy, and
consumer goods.
We would like to request the survey respondent to be someone familiar with the activities done
by your business related to complying with government regulations such as reportorial
requirements and renewal of permits. The purpose of this study is to determine the outlook of the
industry toward government regulations in terms of their perceived ease and/or difficulty in
complying with regulatory requirements.
Your participation in this survey is voluntary. You may decline to answer any question and you
have the right to withdraw from participation at any time. There are neither known risks nor costs
to participating in this activity. Your responses will remain confidential and anonymous. Any
information gathered will only be used for the purpose of our study and reported as a whole.
If you have questions, please contact us at (02) 631-2163 or send an email to mgr@dap.edu.ph.
Thank you!
CONSENT
I have read the foregoing information. I understand that I may withdraw my consent and
discontinue participation at any time without penalty or loss of benefits to which I may otherwise
be entitled. Should I elect to discontinue participation; any information already collected will be
discarded. I have had the opportunity to ask questions and all questions have been answered to
my satisfaction. I consent voluntarily to be a participant in this study.
Signature of Participant
Contact No: Date:
Section A: Background
NOTE FOR SUCCEEDING SECTIONS: For the purpose of this questionnaire, the term “regulatory
agencies” may refer to any national government agency (NGA) or local government unit (LGU) with
regulatory functions (e.g. accreditation, clearance, certification, inspection, licensing, permitting).
B1. Who are the regulatory agencies that you most deal with? If more than one, please list in the
order of importance on your business.
1
2
3
4
5
B2. Which of the following describe the nature of your interaction with the regulatory agencies?
(tick all that apply)
B3. How often do you have to submit information to the regulatory agencies that you most
regularly deal with?
B4. How frequently have your business been inspected and/or audited by regulatory agencies in
the past 3 years?
B5. Please tick the box on the rating column that best corresponds to your answer.
C1. How familiar are you with government regulations that affect your business?
C2. Please indicate to what extent you agree or disagree with the statements below:
Neither
Strongly agree Strongly
Statements Disagree Agree
disagree nor Agree
disagree
a Tax regulations ☐ ☐ ☐ ☐
(e.g. business tax, indirect taxes,
etc.)
b Customs regulations ☐ ☐ ☐ ☐
(e.g. import/export permits, etc.)
c Infrastructure/facilities ☐ ☐ ☐ ☐
regulations
(e.g. building permit, locational
clearance, land-use permit, etc.)
d Technological regulations ☐ ☐ ☐ ☐
(e.g. intellectual property
regulations, product
registrations, etc.)
e Health and safety regulations ☐ ☐ ☐ ☐
(e.g. food safety certification,
sanitation certification, etc.)
f Employment regulations ☐ ☐ ☐ ☐
(e.g. occupational health
regulations, social security
regulations, etc.)
g Environmental regulations ☐ ☐ ☐ ☐
Regulation YES NO
a Tax regulations
☐ ☐
(e.g. business tax, indirect taxes, etc.)
b Customs regulations
☐ ☐
(e.g. import/export permits, etc.)
c Infrastructure/facilities regulations
(e.g. building permit, locational clearance, land-use ☐ ☐
permit, etc.)
d Technological regulations
(e.g. intellectual property regulations, product ☐ ☐
registrations, etc.)
e Health and safety regulations
(e.g. food safety certification, sanitation certification, ☐ ☐
etc.)
f Employment regulations
(e.g. occupational health regulations, social security ☐ ☐
regulations, etc.)
g Environmental regulations
(e.g. wastewater discharges regulation, pollution ☐ ☐
control policy, etc.)
h Administrative regulations
☐ ☐
(e.g. Mayor’s permit, barangay clearance, etc.)
D3. What specific regulations are the most difficult to comply with (kindly cite at least three)?
1
2
3
4
5
☐ YES ☐ NO
D6. In your experience, are you required to provide the same information to a number of different
regulatory agencies?
☐ YES ☐ NO
D7. Do you use online forms for submitting information to regulatory agencies?
☐ YES ☐ NO
If no, why?
D8. Are online forms effective in reducing the difficulty in submitting information to regulatory
agencies?
☐ YES ☐ NO
If so, why?
E2. Please tick the box that best corresponds to your answer.
Neither
Strongly agree Strongly
Disagree Agree
disagree nor Agree
disagree
E3. Are there other fees collected in complying with regulations beyond what is published?
☐ YES ☐ NO
Neither
Strongly agree Strongly
Disagree Agree
disagree nor Agree
disagree
F3. Do you think that the benefits outweigh the costs to comply with government regulations?
☐ YES ☐ NO
F4. Have government regulations been a critical factor in your decision to grow and expand your
business?
☐ YES ☐ NO
☐ YES ☐ NO
Good day!
You have been purposively selected due to your unique expertise and experience to be part of a
study conducted by the Modernizing Government Regulations Program Office of the Development
Academy of the Philippines (DAP).
If you agree to participate, you will be required to answer some questions as part of a key
informant interview. The questions mainly revolve around your experience on health business
regulations, e.g. your issues and concerns with the current regulations, the typical activities you
undergo with various government agencies with regard to regulation compliance, etc.).
Your participation in this survey is voluntary. You may decline to answer any question and you
have the right to withdraw from participation at any time. There are neither known risks nor costs
to participating in this activity. Your responses will remain confidential and anonymous. Any
information gathered will only be used for the purpose of our study and reported as combined
total.
If you have questions, please contact us at (02) 631-2163 or send an email to mgr@dap.edu.ph.
Thank you!
CONSENT FORM
I have read the foregoing information. I understand that I may withdraw my consent and
discontinue participation at any time without penalty or loss of benefits to which I may otherwise
be entitled. Should I elect to discontinue participation; any information already collected will be
discarded. I have had the opportunity to ask questions and all questions have been answered to
my satisfaction. I consent voluntarily to be a participant in this study.
Signature of Participant
Contact No:
Date:
QUESTIONS:
1. What agencies are involved in regulating the setting up, regular operations and closing down
of your health business?
2. What are your transactions with these agencies?
3. Are you aware of any regulations pertaining to your health business? If so what are they and
what do they require?
4. What do you think is the rationale, purposes and intents behind these regulatory
policies/laws/legal issuances?
5. What regulations related to the acquisition of materials and services from suppliers, the flow of
information required by the business, the delivery of goods and services to customer, and the flow
of funds to and from the business affect your operations?
6. What are your main concerns or issues with regard to the current regulations for your business?
7. What are some initiatives or processes, which the agencies implement so as to make your
transactions with them more efficient and convenient?
8. Are you compliant to the regulations? If yes, what facilitates compliance? If no, what are some
obstacles to the regulatory requirements for your business?
9. Do you have any recommendations for the improvement of the regulations affecting your health
business?
CONSENT FORM
I have read the foregoing information. I understand that I may withdraw my consent and
discontinue participation at any time without penalty or loss of benefits to which I may otherwise
be entitled. Should I elect to discontinue participation; any information already collected will be
discarded. I have had the opportunity to ask questions and all questions have been answered to
my satisfaction. I consent voluntarily to be a participant in this study.
Signature of Participant
Contact No:
Date:
Responders SURVEY
A representative from Luzon, Metro Manila, Visayas, and Mindanao operations will be involved
hence n=4 per business type
Mercury 4
Generics Pharmacy 4
Water Station 4
HMO 4
PMA 4
PHA 4
PNA 4
IMAP 4
PDA 4
Optometry 4
Dialysis Center 4
TOTAL 68
Respondent
Responders Facility Name Designation Contact/Email Contact Number
Name
LUZON
Private DR. WILFREDO G. CORTEZ DR. WILFREDO G. Medical
wgcmdc110802@yahoo.com 045-361-2132 / 09189185830
Infirmary HOSPITAL, INC. CORTEZ director
Private JESUS OF NAZARETH GENERAL DR. REMY ROSA Medical jesusofnazarethgen@yahoo.c
(044) 794-1202
Infirmary HOSPITAL G. GARCIA director om
Private
Hospitals Level Dr. Cecilia Tobillo BOT cjt118@hotmail.com 09175009028
1
Private
DR. JOSE E. medical
Hospitals Level AGOO FAMILY HOSPITAL docjoe1959@ yahoo.com (072)607-2708
ASPIRAS, JR. director
1
Private
DR. ROEL TITO A. Medical mission_hospital98@yahoo.co
Hospitals Level Mission Hospital 565-2851 / 655-4337
MARCIAL Director m
1
Private
UHBI - PARAÑAQUE DOCTORS DR. LOIDA S. Medical parañaquedoctors@yahoo.co 776-0288 / 776-0644 / 776-
Hospitals Level
HOSPITAL, INC. PONIO Director m.ph 0648 / 831-1340
2
Private
COMMONWEALTH HOSPITAL JUAN A. Medical
Hospitals Level chmc.ph@gmail.com 930-0000
AND MEDICAL CENTER LAGUNZAD, MD Director
2
Private LOS BAÑOS DOCTORS
DR. ROWENA A. medical
Hospitals Level HOSPITAL AND MEDICAL lbdhmc@yahoo.com 536-0100
PUA director
2 CENTER
Private THE MEDICAL CITY
DR. Benito President & rctecson@medicalcity.com.ph
Hospitals Level COMPOUND, ORTIGAS 988-1000 loc 6314 & 6294
Bengzon CEO / cndiwa@medicalcity.com.ph
3 AVENUE,
Private
DR. EVANGELINA Medical maryjohnstonhospital@yahoo
Hospitals Level Mary Johnston Hospital 245-4021 to 25
C. DURAN Director .com.ph
3
Respondent
Responders Facility Name Designation Contact/Email Contact Number
Name
Private
DE LA SALLE UNIVERSITY DR. GARY N. Medical
Hospitals Level gncarlos@dlshi.edu.ph (046) 481-8000
MEDICAL CENTER CARLOS Director
3
Private Birthing Bet-Nori Health Care Systems, Dr. Godwyn
Owner godwynmd@yahoo.com 09175031902
Home Inc. Bernardo
Private Birthing BLESSED MERCY BIRTHING MERCY V. blessedmercybirthinghomeclin
Clinic Head 0927-6204146
Home HOME CLINIC BAUTISTA ic@yahoo.com
Private Birthing CRESILDA BIRTHING HOME CRESILDA R. cresildakilalalabaon@yahoo.c
Owner 09065237044
Home CLINIC KILALA LABAON om.ph
WELL CARE MATERNITY
Private Birthing LENIELYN F. wellcare_midwife_clinic@yah
MEDICAL & PEDIATRIC CLINIC Clinic Head 6976092
Home JOSEPH, RM oo.com
INC.
Ambulatory
AMBULATORY HEALTH CARE DR. ACHELLE C. medical the_comedian_edz@yahoo.co
Surgical Care 633-6597; 633-5747
INSTITUTE, INC. RONQUILLO director m
Clinic
Private Stand
Dr. Cecilia Bacani Owner cecyderma@yahoo.com 09285032262
Alone Clinic
Dr. Condrado
Private Clinic Dx BOT 09428091089
Quebael
Private Pedia, eduardo_borja_md@yahoo.co
Dr. Edu Borja
Practioner Greenhils m
Dr. Ferdinand
Private Hospital Owner 09175133166
Macababad
Private Dx Clinic Dr. Rafael Yu Owner 09178555428
Private OFW
Dr. Ralf Sison Owner 09173164275
Provider
Private
Dr. Jody Pharma
practitioner jrvd2003@yahoo.com
Dalmacion Consultant
pharma
BOT, Former imapinc@mozcom.com
IMAP Patricia Gomez 09054979705
President patmg55@yahoo.com
Optometry Mildred premildred@yahoo.com 09175497692
Respondent
Responders Facility Name Designation Contact/Email Contact Number
Name
Private Dialysis NEPHROLOGY CENTER OF REY B. JAIME B. Medical
ncm.mla@yahoo.com 5365108
Clinic MANILA TAN, MD director
Value Care Health website: http://www.valucare.
HMO
Systems, Inc. com.ph/
PhilhealthCare, website: https://www.philcare
HMO hotline: (02) 462 1800
lnc. .com.ph/
Pacific Cross
Health Care, lnc. website: http://www.pacificcr
HMO hotline: +63 2 899-8001
(Formerly oss.com.ph/
Bluecross)
Life & Health http://lifeandhealthhmp.com hotline: 742-9750/ 781-9682/
HMO
HMP, Inc. / 732-4415/ 411-0555/ 4116384
Kaiser
website: http://www.kaiserhe
HMO International
althgroup.com/contact.php
Healthgroup, Inc.
Insular Health website: https://www.insularh
HMO
Care, Inc ealthcare.com.ph/
Fortune website: http://www.fortunec
HMO
Medicare, lnc are.com.ph/
Caritas Health website: http://www.caritash
HMO
Shield, Inc. ealthshield.com.ph/
VISAYAS
Private REINHARD WIRTGEN DR. GILBERTO F. Medical rwmh_alegriacebu@yahoo.co (032) 476-8028 / (032) 476-
Infirmary MEMORIAL HOSPITAL MAGALLON director m 7101 / (0916) 920-5475
Private MITIONG-DODING MEMORIAL DR. BIENVENIDO Medical (038) 530-6602 / (0916) 892-
duerohospital@gmail.com
Infirmary HOSPITAL C. MOLINA JR. director 8445
Private
STA. ROMANA-YSON JULIUS CAESAR Y. Medical staromanaysonmemhospital@
Hospitals Level 91613088431
MEMORIAL HOSPITAL STA. ROMANA Director gmail.com
1
Respondent
Responders Facility Name Designation Contact/Email Contact Number
Name
Private
PAULINA LIM MEMORIAL DR. PAULINE L. Medical plmh_guindulman@yahoo.co (038) 510-0299 / (0999) 366-
Hospitals Level
HOSPITAL RAMOS Director m 9822
1
Private
JULIO CARDINAL ROSALES DR. GENALYN B. Medical cardinalhosp@yahoo.com /
Hospitals Level (032) 484-8601
MEMORIAL HOSPITAL LABADAN Director jcrmh_spc@yahoo.com
1
Private
Hospitals Level Dr. Susan Aspiras Owner susanaaspiras@yahoo.com
2
Private
ST. ANTHONY COLLEGE SR. MANILEÑA A.
Hospitals Level Administrator sach_roxas@pldtdsl.net (036) 621-0434/ 621-6004
HOSPITAL LIBO-ON , DC
2
Private
CEBU NORTH GENERAL DR. ROBERTINO L. Medical cebunorthgeneralhospital@ya
Hospitals Level (032) 343-7777
HOSPITAL ESPLANADA Director hoo.com
2
Private
DR. KENNETH T. Medical (035) 225-0510 / (035) 421-
Hospitals Level HOLY CHILD HOSPITAL holy_child65@yahoo.com
COO Director 0991
2
Private
DR. ROLANDO R. Medical
Hospitals Level ILOILO DOCTORS HOSPITAL idhdirect@skyinet.net 337-7702 TO 06
PADILLA Director
3
Private
ADVENTIST MEDICAL CENTER- DR. HECTOR G.
Hospitals Level Administrator bamc_2004@yahoo.com 433-4831
BACOLOD, INC. GAYARES, JR.
3
Private
DR. CESAR A. Medical
Hospitals Level DIVINE WORD HOSPITAL dwhospital2gmail.com 321-4228
AQUITANIA Director
3
Private Birthing
Dr. Marietta Hao Owner 09176278532
Home
JAZMIN LAURE-
Birthing Home JKL Birthing Home Clinic Head jkapunan@yahoo.com 3917122
KAPUNAN, MD
Respondent
Responders Facility Name Designation Contact/Email Contact Number
Name
CATALINA B.
Birthing Home CFC Birthing Center Clinic Head cathy.catubac@yahoo.com 033-5003214
CATUBAC, RM
IMAP LYING-IN CLINIC, INC.-
Birthing Home EMMA S. PLAZA Clinic Head pettepanis@yahoo.com 0916-7197808
SANDINGAN BRANCH
Ambulatory
MEDICUS AMBULATORY DR. JAIME medical medicus_iloilo-
Surgical Care 5085488
HEALTHCARE CENTER MANILA director adm@yahoo.com
Clinic
Private TAHC
MotherBles Birthing Clinic Sis. Eloisa David BOT siseloisa@gmail.com 09178532775
provider
DR. KAREN
METRO CEBU KIDNEY DIALYSIS Medical mck_dialysiscenter@yahoo.co (032) 254-4715 / (0917) 709-
Dialysis Center ROSARIO C.
CENTER, INC. director m 7778
LICUANAN
MINDANAO ARMM
Private OROQUIETA COMMUNITY DR. ANDREA P. Medical
och.mancao@gmail.com (088) 531-1858
Infirmary HOSPITAL MANCAO director
JOSE
Private TIBUNGCO DOCTORS Medical tibungcodoctorshospital@yah
DOMINADOR (82) 2380774
Infirmary HOSPITAL director oo.com
QUITAIN, MD
Private Hospital
Dr. Rashid Chin BOT 09173006689
1
Private
JANUARIA MARCIAL DR. NEREO A. Medical
Hospitals Level jmmhbanga@yahoo.com 9189480269
MEMORIAL HOSPITAL OCSIO Director
1
Private
MIDSAYAP COMMUNITY DR. EMILY C. Medical
Hospitals Level mcdh_012002@yahoo.com (064) 229-8337
DOCTORS HOSPITAL DIZOR Director
1
Private
R. O. DIAGAN COOPERATIVE DR. RENATO G. Medical
Hospitals Level diaganmd_1@yahoo.com (083)552-3942
HOSPITAL DIAGAN Director
1
Private
METRO DAVAO MEDICAL AND YVETTE YENCO- Medical
Hospitals Level mdmrcdavao@yahoo.com.ph (082) 2877777
RESEARCH CENTER, INC. TAN, MD Director
2
Respondent
Responders Facility Name Designation Contact/Email Contact Number
Name
Private
DIGOS DOCTORS' HOSPITAL, RODRIGO P. Medical digosdoctorshospital@yahoo.c
Hospitals Level (82) 5533584
INC. NAVARRO, MD Director om
2
Private
CAGAYAN DE ORO MEDICAL DR. EDNA E. Medical
Hospitals Level cdomedicalcenter@gmail.com (08822) 711-874 to 76
CENTER, INC. RICARTE Director
2
Private DR. RAUL
MARIA REYNA- XAVIER Medical
Hospitals Level WINSTON mrxuh_cdo@yahoo.com (08822) 727530
UNIVERSITY HOSPITAL, INC. Director
3 ANDUTAN
Private DR. BABY
ADVENTIST MEDICAL CENTER- Medical
Hospitals Level DARLENE LL. amc.iligan@gmail.com (063) 221-3029
ILIGAN CITY, INC. Director
3 DELA CRUZ
Private
SAN PEDRO HOSPITAL OF MARCELO L. Medical
Hospitals Level sphadmin@sphdavao.com (82) 2270250
DAVAO CITY, INC. DAHINOG, MD Director
3
DBM PAANAKAN AND FAMILY COSME M.
Birthing Home Clinic Head dbmpaanakan@yahoo.com 9357910121
PLANNING CLINIC MABINI, RM
GRACE ANNE MATERNITY AND FREDESMINDA J.
Birthing Home Clinic Head minda_andunyan@yahoo.com (82) 2985227
FAMILY PLANNING CLINIC ANDUYAN, MD
MS. HERMINIA A. sttheresebirthinghome@yaho
Birthing Home ST. THERESE BIRTHING HOME Owner 9483142507
TELARMA o.com
Ambulatory
SURIGAO HEALTH DR. ROY N. medical surigaohealthspecialist@yaho
Surgical Care 086 8266200
SPECIALISTS', INC. YCONG director o.com
Clinic
Department of Health
Dr. ROLANDO ENRIQUE D. DOMINGO, DPBO
Undersecretary of Health
1
Health Regulations Cluster
reddomingo@doh.gov.ph
(632) 651-7800 local 2901, 2916, 2917
Dr. MARIO C. VILLAVERDE, MPH, MPM, CESO I
Undersecretary of Health
Health Sector Reform Cluster 1
officeofusecmcv@gmail.com
(632) 651-7800 local 2901, 2902, 2903, 2904,
2919 ; TF: 711-0780
DR. LYNDON L. LEE SUY, MPH
Director IV
Health Policy Development and Planning
Bureau (HPDPB) 1
kgronquillo@doh.gov.ph
ken2000_hhrdb@yahoo.com
651-7800 local 1326-1331, 4203-4204, 4250-
4251
DR. MA. THERESA G. VERA, MSc, MHA, CESO
III
Director IV
1
Health Human Resource Development Bureau
mgvera@doh.gov.ph
tgvera@yahoo.com
651-7800 local 4226, 4225
Director IV
1
Health Facilities and Services Regulatory Bureau
(HFSRB)
651-7800 local 2503, 2500, 2505
R. FERDINAND S. SALCEDO, MPH, CESO IV
Director IV
1
Bureau of Quarantine (BOQ)
ferdinandsalcedo@yahoo.com
527-4678, 320-9103
MS. NELA CHARADE G. PUNO, RPh
Director General
1
Food and Drug Administration (FDA)
cgpuno@fda.gov.ph
(632) 857-1999
MARIA LOURDES C. SANTIAGO, MSc, MM,
CESO II
DR.JOVITO SALINAS 1
OIC, Medical Center Chief II
(053) 321-3129, 321-3363 , (053) 321-8724
evrmc.hrms@gmail.com
NORTHERN MINDANAO MEDICAL CENTER
CAPITOL CMPD., CAGAYAN DE ORO CITY
DIOCSON, LOURDES F.
Regional Vice President
1
PhilHealth Regional Office VI (02) 441-7444 loc.
5401
Total 36 2 7 5 50
PHO Iloilo 1
PHO Misamis 1
QC Health Department 1
Iloilo City HO 1
Miagao RHU 1
CDO CHO 1
Total Participants 10 15 10 35
*Assuming there are 5 participants per FGD; lower limit of estimated participants was used
ILOCOS TRAINING AND REGIONAL MEDICAL CENTER DR. EDUARDO M. BADUA III
SAN FERNANDO, LA UNION OIC-Medical Center Chief II
(072) 607-6418, 607-6422
itrmc2010@yahoo.com
DOH Hospitals
BATAAN GENERAL HOSPTAL DR. GLORY V. BALTAZAR
MANAHAN ST., TENEJERO, BALANGA, BATAAN Medical Center Chief II
(047) 237-1274, 237-1275 (TL), 237-3635 (TF)
bgh_bataan2005@yahoo.com.ph